DOCSLIB.ORG

Deletion of Biliverdin Reductase a in Myeloid Cells Promotes Chemokine

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Deletion of Biliverdin Reductase a in Myeloid Cells Promotes Chemokine Deletion of Biliverdin Reductase A in Myeloid Cells Promotes Chemokine Expression and Chemotaxis in Part via a Complement C5a­−C5aR1 Pathway This information is current as of October 2, 2021. Kavita Bisht, Giacomo Canesin, Tasneem Cheytan, Mailin Li, Zsuzsanna Nemeth, Eva Csizmadia, Trent M. Woodruff, David E. Stec, Andrew C. Bulmer, Leo E. Otterbein and Barbara Wegiel J Immunol published online 5 April 2019 Downloaded from http://www.jimmunol.org/content/early/2019/04/04/jimmun ol.1701443 Supplementary http://www.jimmunol.org/content/suppl/2019/04/04/jimmunol.170144 http://www.jimmunol.org/ Material 3.DCSupplemental Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists by guest on October 2, 2021 • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2019 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. Published April 5, 2019, doi:10.4049/jimmunol.1701443 The Journal of Immunology Deletion of Biliverdin Reductase A in Myeloid Cells Promotes Chemokine Expression and Chemotaxis in Part via a Complement C5a–C5aR1 Pathway Kavita Bisht,*,†,1 Giacomo Canesin,*,1 Tasneem Cheytan,* Mailin Li,* Zsuzsanna Nemeth,* Eva Csizmadia,* Trent M. Woodruff,‡ David E. Stec,x Andrew C. Bulmer,{ Leo E. Otterbein,* and Barbara Wegiel* Biliverdin reductase (BVR)-A is a pleotropic enzyme converting biliverdin to bilirubin and a signaling molecule that has cytoprotective and immunomodulatory effects. We recently showed that biliverdin inhibits the expression of complement activa- tion fragment 5a receptor one (C5aR1) in RAW 264.7 macrophages. In this study, we investigated the role of BVR-A in deter- mining macrophage inflammatory phenotype and function via regulation of C5aR1. We assessed expression of C5aR1, M1-like Downloaded from macrophage markers, including chemokines (RANTES, IP-10), as well as chemotaxis in response to LPS and C5a in bone marrow–derived macrophages from BVRfl/fl and LysM-Cre:BVRfl/fl mice (conditional deletion of BVR-A in myeloid cells). In response to LPS, macrophages isolated from LysM-Cre:BVRfl/fl showed significantly elevated levels of C5aR1 as well as chemokines (RANTES, IP10) but not proinflammatory markers, such as iNOS and TNF. An increase in C5aR1 expression was also observed in peritoneal macrophages and several tissues from LysM-Cre:BVRfl/fl mice in a model of endotoxemia. In addition, knockdown of BVR- A resulted in enhanced macrophage chemotaxis toward C5a. Part of the effects of BVR-A deletion on chemotaxis and RANTES http://www.jimmunol.org/ expression were blocked in the presence of a C5aR1 neutralizing Ab, confirming the role of C5a–C5aR1 signaling in mediating the effects of BVR. In summary, BVR-A plays an important role in regulating macrophage chemotaxis in response to C5a via modulation of C5aR1 expression. In addition, macrophages lacking BVR-A are characterized by the expression of M1 polarization–associated chemokines, the levels of which depend in part on C5aR1 signaling. The Journal of Immunology, 2019, 202: 000–000. iliverdin reductase (BVR)-A is a multifunctional protein, BVR-A present on the surface of macrophages is crucial for which mediates the reduction of biliverdin (BV) to bili- mediating anti-inflammatory effects of BV through Akt–IL-10 rubin (BR) and regulates intracellular signaling by acting signaling (5). Our previous work showed that knockdown of B by guest on October 2, 2021 as a kinase and transcriptional regulator (1–3). The conversion of BVR-A also leads to the development of a proinflammatory phe- BV to BR occurs in many cellular compartments; however, the notype in macrophages, which is characterized by elevated pro- majority of BVR-A reactivity is detected in the endoplasmic re- duction of TNF because of increased basal expression of TLR-4 (6). ticulum and cell membrane (4). We have previously showed that Deletion of BVR-A by RNA interference promotes cell death and oxidative stress in response to H2O2 in a similar manner observed with depletion of glutathione (7, 8). Similarly, BVR-A2/2 mice *Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Med- ical School, Boston, MA 02215; †Cancer Care and Biology Program, Mater demonstrate greater oxidative damage to blood components because Research Institute, The University of Queensland, Translational Research Institute, of lower levels of circulating BR (9). Recent studies using condi- Woolloongabba, Queensland 4102, Australia; ‡School of Biomedical Sciences, The x tional deletion of BVR-A in the mouse liver show the importance of University of Queensland, Queensland 4072, Australia; Department of Physiology and Biophysics, The University of Mississippi Medical Center, Jackson, MS 39216; BVR-A in protecting against hepatic steatosis by inhibiting glyco- { and School of Medical Science, Griffith University, Queensland 4222, Australia gen synthase kinase 3b (GSK3b) and activating the peroxisome 1K.B. and G.C. contributed equally. proliferator-activated receptor a (PPARa) (10, 11). Further, BVR-A ORCIDs: 0000-0002-4073-0804 (K.B.); 0000-0002-3318-4550 (G.C.); 0000-0003- deficient animals are more prone to proximal tubular injury in a 2586-6639 (Z.N.); 0000-0003-1382-911X (T.M.W.); 0000-0001-8359-4008 (D.E.S.); model of saturated fatty acid–induced lipotoxicity (12). 0000-0002-7900-0825 (L.E.O.); 0000-0003-0679-8765 (B.W.). The complement system plays a key role in immunity by fa- Received for publication October 13, 2017. Accepted for publication March 11, 2019. cilitating pathogen elimination by opsonization, augmenting Ab production and inflammatory responses (13). It also facilitates This work was supported by National Institutes of Health/National Institute of Dia- betes Digestive and Kidney Diseases Grant R01 DK104714 and start-up funds from clearance of apoptotic and necrotic cells in tissues (14, 15). Ac- the Department of Surgery at Beth Israel Deaconess Medical Center and the Eleanor tivation of complement occurs by one of four different pathways: Shore Harvard Medical School Foundation (to B.W.). classical, lectin, alternative, or extrinsic, and all pathways lead to Address correspondence and reprint requests to Dr. Barbara Wegiel, Department of the cleavage of the central fragments C3 and C5 to generate the Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, 3 Blackfan Circle CLS 613, Boston, MA 02215. E-mail address: [email protected] anaphylatoxins C3a and C5a (16, 17). These small protein frag- The online version of this article contains supplemental material. ments act primarily through their cellular receptors C3aR, com- Abbreviations used in this article: BMDM, bone marrow–derived macrophage; BR, plement activation fragment 5a receptor (C5aR1), and C5aR2, bilirubin; BV, biliverdin; BVR, biliverdin reductase; C5aR1, complement activation respectively (17–19). The C5a–C5aR1 axis has been identified as fragment 5a receptor; qPCR, quantitative PCR; RT, room temperature; shRNA, short a crucial player in inflammation-associated pathologies, such as hairpin RNA; shRNAmir, microRNA-adapted short hairpin RNA. ischemia reperfusion injury, neurodegenerative disorders, athero- Copyright Ó 2019 by The American Association of Immunologists, Inc. 0022-1767/19/$37.50 sclerosis, rheumatoid arthritis, and sepsis (13, 20–26). We have www.jimmunol.org/cgi/doi/10.4049/jimmunol.1701443 2 BVR-A IMPACTS CHEMOTAXIS VIA C5a–C5aR1 SIGNALING previously shown that BV inhibits the expression of C5aR1 in mouse anti–b-actin (Sigma-Aldrich), rabbit anti-iNOS (Santa Cruz Bio- RAW 264.7 macrophages in part via mTOR signaling (27). technology, Santa Cruz, CA), anti-mouse IgG (Cell Signaling Technology, In the current study, we sought to determine a cross-talk between Beverly, MA), or anti-rabbit IgG (Cell Signaling Technology). For flow cytometry, PE anti-mouse CD88 and PE Rat IgG2a (BioLegend), FITC immunomodulatory BVR protein and the C5a–C5aR1 axis in anti-mouse F4.80 and FITC Rat IgG2a (BioLegend), and allophycocyanin macrophages, which are key cells involved in mediating responses anti-mouse CD11b and allophycocyanin Rat IgG2a (BioLegend) were during septic shock. used. For immunohistochemistry, Rat anti-mouse CD88/C5aR1 Ab (clone 10/92; LifeSpan Biosciences, Seattle, WA) was applied. Materials and Methods Animal treatment Animals fl/fl fl/fl BVR controls and LysM-Cre:BVR mice were administrated LPS BVRfl/fl mice were described before (10–12). We replicated most of the (5 mg/kg, i.p.), and tissues were harvested 24 h after injection. Peritoneal experiments in these mice based on our original observation in mice cells were isolated by flushing the mouse peritoneum with 10 ml of ice- generated in house on the 129 background. In-house generated BVRfl/fl cold PBS and spinning them down at 1200 3 g for 5 min. Cells were mice (conditional knockout mice) were based on a targeting construct that stained with selected Abs for 30 min on ice or at room temperature was designed based on PGK Neo FRT/loxP vector. A targeted sequence of (RT) and, thereafter, were immediately analyzed by flow cytometry. exons IV and V of the mouse BVR-A gene was inserted into the SacII site, located upstream of neomycin-resistance gene and flanked by two lox RNA extraction and RT-PCR sites. The same exons were targeted in BVRfl/fl mice from Dr. D.E. Stec’s Total RNA was isolated from cultured cells using RNeasy Plus Mini colony. The fragment of 39 (part of intron IV) arm and 59 (exon VI) arm of Kits (QIAGEN, Valencia, CA), and qPCR was performed as previ- homology were inserted outside the loxP sites between the Hpa-I and Sal-I ously described (6).
Load more

Recommended publications
  • Amplitaq and Amplitaq Gold DNA Polymerase
    AmpliTaq and AmpliTaq Gold DNA Polymerase The Most Referenced Brand of DNA Polymerase in the World Date: 2005-05 Notes: Authors are listed alphabetically J. Biol. Chem. (223) Ezoe, S., I. Matsumura, et al. (2005). "GATA Transcription Factors Inhibit Cytokine-dependent Growth and Survival of a Hematopoietic Cell Line through the Inhibition of STAT3 Activity." J. Biol. Chem. 280(13): 13163-13170. http://www.jbc.org/cgi/content/abstract/280/13/13163 Although GATA-1 and GATA-2 were shown to be essential for the development of hematopoietic cells by gene targeting experiments, they were also reported to inhibit the growth of hematopoietic cells. Therefore, in this study, we examined the effects of GATA-1 and GATA-2 on cytokine signals. A tamoxifen-inducible form of GATA-1 (GATA-1/ERT) showed a minor inhibitory effect on interleukin-3 (IL-3)-dependent growth of an IL-3-dependent cell line Ba/F3. On the other hand, it drastically inhibited TPO-dependent growth and gp130-mediated growth/survival of Ba/F3. Similarly, an estradiol-inducible form of GATA-2 (GATA-2/ER) disrupted thrombopoietin (TPO)-dependent growth and gp130-mediated growth/survival of Ba/F3. As for this mechanism, we found that both GATA-1 and GATA-2 directly bound to STAT3 both in vitro and in vivo and inhibited its DNA-binding activity in gel shift assays and chromatin immunoprecipitation assays, whereas they hardly affected STAT5 activity. In addition, endogenous GATA-1 was found to interact with STAT3 in normal megakaryocytes, suggesting that GATA-1 may inhibit STAT3 activity in normal hematopoietic cells.
    [Show full text]
  • CYP2A6) by P53
    Transcriptional Regulation of Human Stress Responsive Cytochrome P450 2A6 (CYP2A6) by p53 Hao Hu M.Biotech. (Biotechnology) 2012 The University of Queensland B.B.A. 2009 University of Electronic Science and Technology of China B.Sc. (Pharmacy) 2009 University of Electronic Science and Technology of China A thesis submitted for the degree of Doctor of Philosophy at The University of Queensland in 2016 School of Medicine ABSTRACT Human cytochrome P450 (CYP) 2A6 is highly expressed in the liver and the encoding gene is regulated by various stress activated transcription factors, such as the nuclear factor (erythroid-derived 2)-like 2 (Nrf-2). Unlike the other xenobiotic metabolising CYP enzymes (XMEs), CYP2A6 only plays a minor role in xenobiotic metabolism. The CYP2A6 is highly induced by multiple forms of cellular stress conditions, where XMEs expression is normally inhibited. Recent findings suggest that the CYP2A6 plays an important role in regulating BR homeostasis. A computer based sequence analysis on the 3 kb proximate CYP2A6 promoter revealed several putative binding sites for p53, a protein that mediates regulation of antioxidant and apoptosis pathways. In this study, the role of p53 in CYP2A6 gene regulation is demonstrated. The site closest to transcription start site (TSS) is highly homologous with the p53 consensus sequence. The p53 responsiveness of this site was confirmed by transfections with various stepwise deleted of CYP2A6-5’-Luc constructs containing the putative p53RE. Deletion of the putative p53RE resulted in a total abolishment of p53 responsiveness of CYP2A6 promoter. Specific binding of p53 to the putative p53RE was detected by electrophoresis mobility shift assay.
    [Show full text]
  • Characterisation of Bilirubin Metabolic Pathway in Hepatic Mitochondria Siti Nur Fadzilah Muhsain M.Sc
    Characterisation of Bilirubin Metabolic Pathway in Hepatic Mitochondria Siti Nur Fadzilah Muhsain M.Sc. (Medical Research) 2005 Universiti Sains Malaysia Postgrad. Dip. (Toxicology) 2003 University of Surrey B.Sc.(Biomed. Sc.) 2000 Universiti Putra Malaysia A thesis submitted for the degree of Doctor of Philosophy at The University of Queensland in 2014 School of Medicine ABSTRACT Bilirubin (BR), a toxic waste product of degraded haem, is a potent antioxidant at physiological concentrations. To achieve the maximum benefit of BR, its intracellular level needs to be carefully regulated. A system comprising of two enzymes, haem oxygenase-1 (HMOX1) and cytochrome P450 2A5 (CYP2A5) exists in the endoplasmic reticulum (ER), responsible for regulating BR homeostasis. This system is induced in response to oxidative stress. In this thesis, oxidative stress caused accumulation of these enzymes in mitochondria — major producers and targets of reactive oxygen species (ROS) — is demonstrated. To understand the significance of this intracellular targeting, properties of microsomal and mitochondrial BR metabolising enzymes were compared and the capacity of mitochondrial CYP2A5 to oxidise BR in response to oxidative stress is reported. Microsomes and mitochondrial fractions were isolated from liver homogenates of DBA/2J mice, administered with sub-toxic dose of pyrazole, an oxidant stressor. The purity of extracted organelles was determined by analysing the expressions and activities of their respective marker enzymes. HMOX1 and CYP2A5 were significantly increased in microsomes and even more so in mitochondria in response to pyrazole-induced oxidative stress. By contrast, the treatment did not increase either microsomes or mitochondrial Uridine-diphosphate-glucuronosyltransferase 1A1 (UGT1A1), the sole enzyme that catalyses BR elimination through glucuronidation.
    [Show full text]
  • Heme Oxygenase-1 Regulates Mitochondrial Quality Control in the Heart
    RESEARCH ARTICLE Heme oxygenase-1 regulates mitochondrial quality control in the heart Travis D. Hull,1,2 Ravindra Boddu,1,3 Lingling Guo,2,3 Cornelia C. Tisher,1,3 Amie M. Traylor,1,3 Bindiya Patel,1,4 Reny Joseph,1,3 Sumanth D. Prabhu,1,4,5 Hagir B. Suliman,6 Claude A. Piantadosi,7 Anupam Agarwal,1,3,5 and James F. George2,3,4 1Department of Medicine, 2Department of Surgery, 3Nephrology Research and Training Center, and 4Comprehensive Cardiovascular Center, University of Alabama at Birmingham, Birmingham, Alabama, USA. 5Department of Veterans Affairs, Birmingham, Alabama, USA. 6Department of Anesthesiology and 7Department of Pulmonary, Allergy and Critical Care, Duke University School of Medicine, Durham, North Carolina, USA. The cardioprotective inducible enzyme heme oxygenase-1 (HO-1) degrades prooxidant heme into equimolar quantities of carbon monoxide, biliverdin, and iron. We hypothesized that HO-1 mediates cardiac protection, at least in part, by regulating mitochondrial quality control. We treated WT and HO-1 transgenic mice with the known mitochondrial toxin, doxorubicin (DOX). Relative to WT mice, mice globally overexpressing human HO-1 were protected from DOX-induced dilated cardiomyopathy, cardiac cytoarchitectural derangement, and infiltration of CD11b+ mononuclear phagocytes. Cardiac-specific overexpression of HO-1 ameliorated DOX-mediated dilation of the sarcoplasmic reticulum as well as mitochondrial disorganization in the form of mitochondrial fragmentation and increased numbers of damaged mitochondria in autophagic vacuoles. HO-1 overexpression promotes mitochondrial biogenesis by upregulating protein expression of NRF1, PGC1α, and TFAM, which was inhibited in WT animals treated with DOX. Concomitantly, HO-1 overexpression inhibited the upregulation of the mitochondrial fission mediator Fis1 and resulted in increased expression of the fusion mediators, Mfn1 and Mfn2.
    [Show full text]
  • CDH12 Cadherin 12, Type 2 N-Cadherin 2 RPL5 Ribosomal
    5 6 6 5 . 4 2 1 1 1 2 4 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 2 2 A A A A A A A A A A A A A A A A A A A A C C C C C C C C C C C C C C C C C C C C R R R R R R R R R R R R R R R R R R R R B , B B B B B B B B B B B B B B B B B B B , 9 , , , , 4 , , 3 0 , , , , , , , , 6 2 , , 5 , 0 8 6 4 , 7 5 7 0 2 8 9 1 3 3 3 1 1 7 5 0 4 1 4 0 7 1 0 2 0 6 7 8 0 2 5 7 8 0 3 8 5 4 9 0 1 0 8 8 3 5 6 7 4 7 9 5 2 1 1 8 2 2 1 7 9 6 2 1 7 1 1 0 4 5 3 5 8 9 1 0 0 4 2 5 0 8 1 4 1 6 9 0 0 6 3 6 9 1 0 9 0 3 8 1 3 5 6 3 6 0 4 2 6 1 0 1 2 1 9 9 7 9 5 7 1 5 8 9 8 8 2 1 9 9 1 1 1 9 6 9 8 9 7 8 4 5 8 8 6 4 8 1 1 2 8 6 2 7 9 8 3 5 4 3 2 1 7 9 5 3 1 3 2 1 2 9 5 1 1 1 1 1 1 5 9 5 3 2 6 3 4 1 3 1 1 4 1 4 1 7 1 3 4 3 2 7 6 4 2 7 2 1 2 1 5 1 6 3 5 6 1 3 6 4 7 1 6 5 1 1 4 1 6 1 7 6 4 7 e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m
    [Show full text]
  • Supplementary Table 1 List of 335 Genes Differentially Expressed Between Primary (P) and Metastatic (M) Tumours
    Supplementary Table 1 List of 335 genes differentially expressed between primary (P) and metastatic (M) tumours Spot ID I.M.A.G.E. UniGene Symbol Name Clone ID Cluster 296529 296529 In multiple clusters 731356 731356 Hs.140452 M6PRBP1 mannose-6-phosphate receptor binding protein 1 840942 840942 Hs.368409 HLA-DPB1 major histocompatibility complex, class II, DP beta 1 142122 142122 Hs.115912 AFAP actin filament associated protein 1891918 1891918 Hs.90073 CSE1L CSE1 chromosome segregation 1-like (yeast) 1323432 1323432 Hs.303154 IDS iduronate 2-sulfatase (Hunter syndrome) 788566 788566 Hs.80296 PCP4 Purkinje cell protein 4 591281 591281 Hs.80680 MVP major vault protein 815530 815530 Hs.172813 ARHGEF7 Rho guanine nucleotide exchange factor (GEF) 7 825312 825312 Hs.246310 ATP5J ATP synthase, H+ transporting, mitochondrial F0 complex, subunit F6 784830 784830 Hs.412842 C10orf7 chromosome 10 open reading frame 7 840878 840878 Hs.75616 DHCR24 24-dehydrocholesterol reductase 669443 669443 Hs.158195 HSF2 heat shock transcription factor 2 2485436 2485436 Data not found 82903 82903 Hs.370937 TAPBP TAP binding protein (tapasin) 771258 771258 Hs.85258 CD8A CD8 antigen, alpha polypeptide (p32) 85128 85128 Hs.8986 C1QB complement component 1, q subcomponent, beta polypeptide 41929 41929 Hs.39252 PICALM phosphatidylinositol binding clathrin assembly protein 148469 148469 Hs.9963 TYROBP TYRO protein tyrosine kinase binding protein 415145 415145 Hs.1376 HSD11B2 hydroxysteroid (11-beta) dehydrogenase 2 810017 810017 Hs.179657 PLAUR plasminogen activator,
    [Show full text]
  • Biocatalyzed Synthesis of Statins: a Sustainable Strategy for the Preparation of Valuable Drugs
    catalysts Review Biocatalyzed Synthesis of Statins: A Sustainable Strategy for the Preparation of Valuable Drugs Pilar Hoyos 1, Vittorio Pace 2 and Andrés R. Alcántara 1,* 1 Department of Chemistry in Pharmaceutical Sciences, Faculty of Pharmacy, Complutense University of Madrid, Campus de Moncloa, E-28040 Madrid, Spain; [email protected] 2 Department of Pharmaceutical Chemistry, Faculty of Life Sciences, Althanstrasse 14, A-1090 Vienna, Austria; [email protected] * Correspondence: [email protected]; Tel.: +34-91-394-1823 Received: 25 February 2019; Accepted: 9 March 2019; Published: 14 March 2019 Abstract: Statins, inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, are the largest selling class of drugs prescribed for the pharmacological treatment of hypercholesterolemia and dyslipidaemia. Statins also possess other therapeutic effects, called pleiotropic, because the blockade of the conversion of HMG-CoA to (R)-mevalonate produces a concomitant inhibition of the biosynthesis of numerous isoprenoid metabolites (e.g., geranylgeranyl pyrophosphate (GGPP) or farnesyl pyrophosphate (FPP)). Thus, the prenylation of several cell signalling proteins (small GTPase family members: Ras, Rac, and Rho) is hampered, so that these molecular switches, controlling multiple pathways and cell functions (maintenance of cell shape, motility, factor secretion, differentiation, and proliferation) are regulated, leading to beneficial effects in cardiovascular health, regulation of the immune system, anti-inflammatory and immunosuppressive properties, prevention and treatment of sepsis, treatment of autoimmune diseases, osteoporosis, kidney and neurological disorders, or even in cancer therapy. Thus, there is a growing interest in developing more sustainable protocols for preparation of statins, and the introduction of biocatalyzed steps into the synthetic pathways is highly advantageous—synthetic routes are conducted under mild reaction conditions, at ambient temperature, and can use water as a reaction medium in many cases.
    [Show full text]
  • Identification of Systemic Immune Response Markers Through
    Gray et al. Veterinary Research (2015) 46:7 DOI 10.1186/s13567-014-0138-z VETERINARY RESEARCH RESEARCH Open Access Identification of systemic immune response markers through metabolomic profiling of plasma from calves given an intra-nasally delivered respiratory vaccine Darren W Gray1*, Michael D Welsh2, Simon Doherty2, Fawad Mansoor2, Olivier P Chevallier1, Christopher T Elliott1 and Mark H Mooney1 Abstract Vaccination procedures within the cattle industry are important disease control tools to minimize economic and welfare burdens associated with respiratory pathogens. However, new vaccine, antigen and carrier technologies are required to combat emerging viral strains and enhance the efficacy of respiratory vaccines, particularly at the point of pathogen entry. New technologies, specifically metabolomic profiling, could be applied to identify metabolite immune-correlates representative of immune protection following vaccination aiding in the design and screening of vaccine candidates. This study for the first time demonstrates the ability of untargeted UPLC-MS metabolomic profiling to identify metabolite immune correlates characteristic of immune responses following mucosal vaccination in calves. Male Holstein Friesian calves were vaccinated with Pfizer Rispoval® PI3 + RSV intranasal vaccine and metabolomic profiling of post-vaccination plasma revealed 12 metabolites whose peak intensities differed significantly from controls. Plasma levels of glycocholic acid, N-[(3α,5β,12α)-3,12-Dihydroxy-7,24-dioxocholan-24-yl]glycine, uric acid and
    [Show full text]
  • Biliverdin Reductase: a Major Physiologic Cytoprotectant
    Biliverdin reductase: A major physiologic cytoprotectant David E. Baran˜ ano*, Mahil Rao*, Christopher D. Ferris†, and Solomon H. Snyder*‡§¶ Departments of *Neuroscience, ‡Pharmacology and Molecular Sciences, and §Psychiatry and Behavioral Sciences, The Johns Hopkins University School of Medicine, Baltimore, MD 21205; and †Department of Medicine, Division of Gastroenterology, C-2104 Medical Center North, Vanderbilt University Medical Center, Nashville, TN 37232-2279 Contributed by Solomon H. Snyder, October 16, 2002 Bilirubin, an abundant pigment that causes jaundice, has long hypothesize that bilirubin acts in a catalytic fashion whereby lacked any clear physiologic role. It arises from enzymatic reduction bilirubin oxidized to biliverdin is rapidly reduced back to bili- by biliverdin reductase of biliverdin, a product of heme oxygenase rubin, a process that could readily afford 10,000-fold amplifica- activity. Bilirubin is a potent antioxidant that we show can protect tion (13). Here we establish that a redox cycle based on BVRA cells from a 10,000-fold excess of H2O2. We report that bilirubin is activity provides physiologic cytoprotection as BVRA depletion a major physiologic antioxidant cytoprotectant. Thus, cellular de- exacerbates the formation of reactive oxygen species (ROS) and pletion of bilirubin by RNA interference markedly augments tissue augments cell death. levels of reactive oxygen species and causes apoptotic cell death. Depletion of glutathione, generally regarded as a physiologic Methods antioxidant cytoprotectant, elicits lesser increases in reactive ox- All chemicals were obtained from Sigma unless otherwise ygen species and cell death. The potent physiologic antioxidant indicated. actions of bilirubin reflect an amplification cycle whereby bilirubin, acting as an antioxidant, is itself oxidized to biliverdin and then Cell Culture and Viability Measurements.
    [Show full text]
  • The Extent of Intracellular Accumulation of Bilirubin Determines Its Anti- Or Pro-Oxidant Effect
    International Journal of Molecular Sciences Article The Extent of Intracellular Accumulation of Bilirubin Determines Its Anti- or Pro-Oxidant Effect Annalisa Bianco 1,2, Aleš Dvoˇrák 3 , Nikola Capková 3, Camille Gironde 4, Claudio Tiribelli 1 , Christophe Furger 4, Libor Vitek 3,5 and Cristina Bellarosa 1,* 1 Italian Liver Foundation (FIF), Bldg Q—AREA Science Park Basovizza, SS14 Km 163,5, 34149 Trieste, Italy; [email protected] (A.B.); [email protected] (C.T.) 2 Department of Life Sciences, University of Trieste, 34127 Trieste, Italy 3 Institute of Medical Biochemistry and Laboratory Diagnostics, Faculty General Hospital and 1st Faculty of Medicine, Charles University, 121 08 Prague 2, Czech Republic; [email protected] (A.D.); [email protected] (N.C.); [email protected] (L.V.) 4 AOP/MH2F Team, LAAS-CNRS, 7 avenue de l’Europe, 31400 Toulouse, France; [email protected] (C.G.); [email protected] (C.F.) 5 4th Department of Internal Medicine, Faculty General Hospital and 1st Faculty of Medicine, Charles University, 121 08 Prague 2, Czech Republic * Correspondence: [email protected] Received: 24 September 2020; Accepted: 28 October 2020; Published: 30 October 2020 Abstract: Background: Severe hyperbilirubinemia can cause permanent neurological damage in particular in neonates, whereas mildly elevated serum bilirubin protects from various oxidative stress-mediated diseases. The present work aimed to establish the intracellular unconjugated bilirubin concentrations (iUCB) thresholds differentiating between anti- and pro-oxidant effects. Methods: Hepatic (HepG2), heart endothelial (H5V), kidney tubular (HK2) and neuronal (SH-SY5Y) cell lines were exposed to increasing concentration of bilirubin. iUCB, cytotoxicity, intracellular reactive oxygen species (ROS) concentrations, and antioxidant capacity (50% efficacy concentration (EC50)) were determined.
    [Show full text]
  • ©Ferrata Storti Foundation
    Original Articles T-cell/histiocyte-rich large B-cell lymphoma shows transcriptional features suggestive of a tolerogenic host immune response Peter Van Loo,1,2,3 Thomas Tousseyn,4 Vera Vanhentenrijk,4 Daan Dierickx,5 Agnieszka Malecka,6 Isabelle Vanden Bempt,4 Gregor Verhoef,5 Jan Delabie,6 Peter Marynen,1,2 Patrick Matthys,7 and Chris De Wolf-Peeters4 1Department of Molecular and Developmental Genetics, VIB, Leuven, Belgium; 2Department of Human Genetics, K.U.Leuven, Leuven, Belgium; 3Bioinformatics Group, Department of Electrical Engineering, K.U.Leuven, Leuven, Belgium; 4Department of Pathology, University Hospitals K.U.Leuven, Leuven, Belgium; 5Department of Hematology, University Hospitals K.U.Leuven, Leuven, Belgium; 6Department of Pathology, The Norwegian Radium Hospital, University of Oslo, Oslo, Norway, and 7Department of Microbiology and Immunology, Rega Institute for Medical Research, K.U.Leuven, Leuven, Belgium Citation: Van Loo P, Tousseyn T, Vanhentenrijk V, Dierickx D, Malecka A, Vanden Bempt I, Verhoef G, Delabie J, Marynen P, Matthys P, and De Wolf-Peeters C. T-cell/histiocyte-rich large B-cell lymphoma shows transcriptional features suggestive of a tolero- genic host immune response. Haematologica. 2010;95:440-448. doi:10.3324/haematol.2009.009647 The Online Supplementary Tables S1-5 are in separate PDF files Supplementary Design and Methods One microgram of total RNA was reverse transcribed using random primers and SuperScript II (Invitrogen, Merelbeke, Validation of microarray results by real-time quantitative Belgium), as recommended by the manufacturer. Relative reverse transcriptase polymerase chain reaction quantification was subsequently performed using the compar- Ten genes measured by microarray gene expression profil- ative CT method (see User Bulletin #2: Relative Quantitation ing were validated by real-time quantitative reverse transcrip- of Gene Expression, Applied Biosystems).
    [Show full text]
  • Bacterial Heme Biosynthesis and Its Biotechnological Application
    Appl Microbiol Biotechnol (2003) 63: 115–127 DOI 10.1007/s00253-003-1432-2 MINI-REVIEW N. Frankenberg . J. Moser . D. Jahn Bacterial heme biosynthesis and its biotechnological application Received: 23 June 2003 / Revised: 22 August 2003 / Accepted: 26 July 2003 / Published online: 16 September 2003 # Springer-Verlag 2003 Abstract Proteins carrying a prosthetic heme group are The nickel-containing yellow coenzyme F430 is the vital parts of bacterial energy conserving and stress prosthetic group of methyl-coenzyme M reductase that response systems. They also mediate complex enzymatic catalyzes the final step of methane formation in methano- reactions and regulatory processes. Here, we review the genenic archaea (Thauer and Bonacker 1994). The pink multistep biosynthetic pathway of heme formation includ- cobalt-containing vitamin B12 derivatives are the most ing the enzymes involved and reaction mechanisms. complex known tetrapyrroles (Martens et al. 2002). They Potential biotechnological implications are discussed. are involved in multiple enzymatic reactions, e.g., radical- dependent nucleotide reduction and methyl transfer. The iron-chelating yellow-greenish siroheme is required for the Introduction six electron transfer reactions during assimilatory nitrite or sulfite reduction (Raux et al. 2003). The green pigment Structure and function of tetrapyrroles heme d1, is part of the dissimilatory nitrite reductase in Pseudomonads and is a typical porphinoid that differs Compounds of the tetrapyrrole class are characterized by significantly in structure and color from the other their four five-membered pyrrole rings, usually linked porphyrin-based hemes (Chang 1994). together via single atom bridges (Fig. 1). The four rings of The other commonly found tetrapyrrole structures are the macrocycle are labelled clockwise A–D starting with the open-chain molecules that are all derived from cleaved the first of the three symmetric rings with regard to the macrocycles.
    [Show full text]